Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
29.4M
-
Shares change
-
+2.12M
-
Total reported value, excl. options
-
$435M
-
Value change
-
-$1.46M
-
Put/Call ratio
-
0.14
-
Number of buys
-
79
-
Number of sells
-
-41
-
Price
-
$14.80
Significant Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q4 2016
139 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock as of Q4 2016.
Evolent Health, Inc. - Class A Common Stock (EVH) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.4M shares
of 112M outstanding shares and own 26.36% of the company stock.
Largest 10 shareholders include Pennant Capital Management, LLC (2.76M shares), JPMORGAN CHASE & CO (2.27M shares), FMR LLC (2.24M shares), VANGUARD GROUP INC (2.14M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (2.13M shares), TPG Group Holdings (SBS) Advisors, Inc. (1.7M shares), BLAIR WILLIAM & CO/IL (1.55M shares), TimesSquare Capital Management, LLC (1.37M shares), PEREGRINE CAPITAL MANAGEMENT LLC (1.27M shares), and Elk Creek Partners, LLC (949K shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.